CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
Hee Jun Lee, Hee Seung Kim, Noh Hyun Park, Hyun Hoon Chung, Jae Weon Kim, Yong Sang Song
Cancer Research and Treatment. 2013;45(1):40-47.   Published online 2013 March 31    DOI: https://doi.org/10.4143/crt.2013.45.1.40

Excel Download

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
Cancer Research and Treatment. 2013;45(1):40-47   Crossref logo
Link1 Link2

Oxaliplatin Plus High-Dose Leucovorin and 5-Fluorouracil (FOLFOX 4) in Platinum-Resistant and Taxane-Pretreated Ovarian Cancer: A Phase II Study
Yearbook of Oncology. 2006;2006:128   Crossref logo
Link1 Link2

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer
BMC Cancer. 2018;18(1):   Crossref logo
Link1 Link2 Link3

Oxaliplatin, fluorouracil and leucovorin (FOLFOX) as first-line chemotherapy for metastatic or recurrent colorectal cancer patients
Chinese Journal of Clinical Oncology. 2007;4(6):397-400   Crossref logo
Link1 Link2 Link3

Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: A phase II study
Gynecologic Oncology. 2004;95(1):165-172   Crossref logo
Link1 Link2

PCN66 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED COLON-RECTUM CANCER IN CHINA
Value in Health. 2010;13(7):A263   Crossref logo
Link1 Link2

PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA
Value in Health. 2010;13(7):A514   Crossref logo
Link1 Link2

All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial
Trials. 2019;20(1):   Crossref logo
Link1 Link2 Link3

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

Cancer Management and Research. 2019;Volume 11:10419-10426   Crossref logo
Link1 Link2

Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients
Medical Oncology. 2011;29(2):418-424   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.